Selectis Health GBCS
OTC GBCS
$5.71 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Selectis Health (GBCS) Gains from Investment Securities (2017)

Selectis Health (GBCS) posted Gains from Investment Securities of $42191.0 for Q4 2017, up 113.25% sequentially from $19785.0 in Q3 2017.

Analysis

Selectis Health (GBCS) Gains from Investment Securities (2017) Analysis & Trends

Selectis Health has reported Gains from Investment Securities for 1 years, with the latest figure at $42191.0 in Q4 2017.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $42191.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $121435.0 (changed N/A YoY) and the FY2017 annual result came in at $121435.0, up 18.73% from the prior year.
  • Gains from Investment Securities grew to $42191.0 in Q4 2017 per GBCS's latest filing, from $19785.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $42565.0 in Q2 2017 and troughed at $16894.0 in Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn
10 Selectis Health 17.51 Mn 9.78 Mn 594,665.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 42,191.00
Sep 30, 2017 19,785.00
Jun 30, 2017 42,565.00
Mar 31, 2017 16,894.00